Introduction
Influenza infection is a leading cause of preventable morbidity and mortality in the United States and is associated with a significantly increased risk of hospitalization and death in vulnerable populations [1, 2] . Person-to-person transmission in the healthcare setting occurs through infected patients, visitors, and healthcare workers (HCWs), some of whom are asymptomatic [3] . HCWs often work with symptoms of influenza-like illness (ILI), further increasing the risk of transmission to vulnerable hospitalized patients [4 ,5 ] . Vaccination of HCWs against influenza is an important component of infection control in healthcare settings [6 ] . Numerous professional organizations have recommended annual HCW influenza vaccination as a core patient-safety practice. Despite these recommendations, HCW vaccination rates remain disappointingly low [7, 8] . In response to sustained low vaccination rates, many institutions have opted to require influenza vaccination as a condition of employment [9 ,10,11 ,12 ,13,14
,15 ]. Mandatory HCW influenza vaccination is now recommended by leading professional societies [6 ,16 ] and may be used in the future as a healthcare quality and safety measure. The following are the professional organizations recommending and opposing mandatory HCW influenza vaccination: In this article, we will review current strategies to increase HCW influenza vaccination coverage, address criticisms of HCW influenza vaccination, and consider the use of HCW influenza vaccination as a quality and patient-safety measure.
Current strategies to improve healthcare worker influenza vaccination
Influenza vaccination is a key component of a comprehensive institutional infection control program aimed at reducing healthcare-associated respiratory infection. In addition to vaccination, rapid detection of infected patients, source control with isolation and/or masking as recommended, patient cohorting, HCW adherence to hand hygiene and respiratory etiquette, work restriction for ill HCWs, policies discouraging presenteeism, visitation restrictions for those with respiratory illness, and antiviral prophylaxis as indicated are important [6 ,8,17-19] . Thus, HCW influenza vaccination is viewed as a subset of an institution's infection control program and not a replacement for it. Specific institutional approaches for improving HCW influenza vaccination rates were outlined in a 2005 Society for Healthcare Epidemiology in America (SHEA) position paper [7] . The key elements of such a program include annual vaccination, administrative support and leadership, targeted education campaigns, provision of vaccine at no cost, easy access to vaccine, declination statements, and system-wide surveillance [7] . All of the above elements remain important in promoting HCW influenza vaccination, yet comprehensive campaigns have met with limited success. A 2009 review showed the relative and somewhat modest improvement in HCW vaccination rate with various interventions, including declination statements [20] . Published reports of the effectiveness of voluntary comprehensive HCW vaccination programs rarely exceed rates above 75%. Ajenjo et al. [21 ] reviewed the 10-year HCW vaccination experience of BJC Healthcare in St. Louis, Missouri, USA. From 1997 to 2007, multiple interventions were attempted to improve HCW vaccination, and vaccination rates improved from 45 to 72% during that time [21 ] . Notable interventions during the decade experience included peer-to-peer quality comparisons, intrahospital competitions, senior leadership support, and declination statements [21 ] . Although this study could be used to tout the success of comprehensive HCW vaccination programs, it also reflects a common and frustrating experience among healthcare organizations throughout the United States: substantial institutional resources were allocated and improvements were made, but three out of every 10 HCWs remained unvaccinated.
Mandatory vaccination programs
Virginia Mason Medical Center in Seattle, Washington, USA altered the traditional paradigm of HCW influenza vaccination. In 2005, they became the first healthcare system in the United States to require influenza vaccination as a condition of employment [9 ,22] . Since that time, several healthcare facilities have implemented mandatory vaccination programs with dramatic success, routinely achieving vaccination rates greater than 95% [10,11 ,12
,13,14 ,15 ,23]. Figure 1 illustrates the improvement in HCW vaccination rates achieved by mandatory influenza vaccination programs in large health systems. An updated list of mandatory HCW influenza vaccination programs is available at www.immunize.org [23] . Given the success of these programs, mandatory HCW influenza vaccination as part of a comprehensive vaccination and infection control program appears to be the most effective means to achieve an acceptable HCW vaccination rate and reduce healthcare-associated influenza infections.
Although mandatory HCW influenza vaccination programs may be implemented differently, they should include the programmatic elements that have been used traditionally in HCW influenza vaccination programs [7] . Mandatory vaccination programs differ primarily in their vaccine exemption policy and treatment of unvaccinated HCWs. Exemption policies can be limited to medical exemptions only, broadened to include religious exemptions [ encouraged [11 ] to wear a surgical mask during patient care activities. The evidence behind requiring masks for unvaccinated HCWs is controversial. At the Robert Koch Institute in Germany, a mask-use requirement was temporally associated with a rise in vaccination rate from 33.1 to 51.7% over the course of 10 days following policy implementation [24] . Some healthcare programs allow for re-assignment of unvaccinated HCWs during influenza season, whereas other programs suspend unvaccinated HCWs without pay during outbreaks of influenza or require daily antiviral prophylaxis for unvaccinated HCWs [25, 26] 
Criticism of mandatory healthcare worker influenza vaccination
Mandatory HCW influenza vaccination programs have been criticized mostly by those who believe that mandatory HCW vaccination infringes on employee autonomy. Yet some criticism of mandatory HCW influenza vaccination blurs the distinction between criticism of HCW policy and criticism of influenza vaccine effectiveness. For example, the American College of Occupational and Environmental Medicine (ACOEM) guidance statement on HCW influenza vaccination states that 'current evidence regarding the benefit of influenza vaccination in HCW as a tool to protect patients is inadequate to override the worker's autonomy to refuse vaccination' [27] . This statement implies a lack of proven effectiveness for HCW influenza vaccine in protecting patients from influenza but it is couched within criticism of mandatory HCW vaccination and not criticism of influenza vaccination. We will address criticism of both mandatory HCW vaccination and influenza vaccination, as overcoming this criticism is important to the success of any HCW influenza vaccination program.
Some have argued that mandatory influenza vaccination is coercive, invasive, and places patient protection above HCW autonomy [6 , [27] [28] [29] . Although it is important to recognize these arguments, it is also important to place these arguments within the context of a HCW's ethical duty to protect patient safety [6 ,30] . This duty consists of acting in a patient's interest, working to protect vulnerable patients and not placing patients at undue risk of harm [6 ] . HCWs are already faced with mandatory vaccination (e.g. varicella) and annual invasive procedures (e.g. tuberculin skin testing), and the legal precedent of mandatory vaccination is established [6 ,31] . Given the low risk of harm related to influenza vaccination [32] , the ethical duty to protect patients supersedes the burden of yearly influenza vaccination. With regard to antagonism between employee and employer, evidence is mixed. Several employee unions have sued healthcare systems to end mandatory HCW influenza vaccination programs, yet surveys in several healthcare systems have shown that a majority of HCWs support mandatory HCW influenza vaccination [12 ,33 ,34 ,35] .
Some argue against mandatory HCW influenza vaccination purely on the basis of HCW autonomy, whereas others use a general criticism of influenza vaccine effectiveness. Evaluation of influenza vaccine effectiveness is difficult and is hampered by insufficient diagnostic accuracy and variable vaccine efficacy. First, we will consider these limitations, and then we will address criticism of influenza vaccine effectiveness. The diagnostic criteria for influenza infection are imperfect and the nuances of influenza diagnostic testing allow for criticism of study design and methods. Influenza studies vary in their use of diagnostic criteria, from the sensitive definition of ILI to the specific definition of laboratoryconfirmed influenza. Unfortunately, both methods present problems for researchers. The sensitivity of ILI has been questioned by studies showing that laboratory-confirmed influenza cases do not always meet the definition of ILI [36] . Although PCR for influenza is highly sensitive and specific [37] , it is limited by the necessity of ILI as a screening method for diagnostic testing in research protocols. Other methods for diagnostic testing are either labor-intensive (e.g. cell culture, paired serology) or lack sensitivity (e.g. antigen testing) [38] . The efficacy of influenza vaccination is variable and depends upon both the host and the antigenic match between the vaccine and circulating strains. The efficacy of influenza vaccination is of particular concern in hospitalized elderly adults [39] . However, in a season in which influenza vaccine matches circulating influenza strains, HCWs should achieve adequate immune response to influenza vaccination [40, 41] .
The effect of HCW influenza vaccination on patient outcomes is controversial. A recent Cochrane review criticized the methodology of studies evaluating the effect of HCW influenza vaccine on elderly patient outcomes [42 ] . Three cluster-randomized controlled trials and one prospective cohort study have shown a protective effect of HCW influenza vaccination on allcause mortality in residents of long-term care facilities, and these studies were combined for meta-analysis in the Cochrane review; an additional cluster-randomized trial which did not show reduced mortality was also included [42 ,43-48] . The protective effect of HCW influenza vaccination on all-cause mortality remained significant in the meta-analysis but was not significant for laboratoryconfirmed influenza or pneumonia, and the authors criticized the use of all-cause mortality as an outcome metric in HCW influenza vaccine effectiveness studies [42 ,47] . The positive and negative aspects of using allcause mortality in influenza vaccine efficacy studies are outlined in reviews by Simonsen et al. [49] and Nichol [50] . Although methodological concerns exist, the combined results of the meta-analysis of HCW influenza vaccination show a reduction in patient mortality and cannot be ignored. Additionally, the biologic plausibility of HCW influenza vaccination in protecting patients is unmistakable as herd immunity to other vaccine-preventable illnesses is an established precedent. Thus, the recommendation for HCW influenza vaccination for patient protection is supported both in concept and in practice.
As available studies have shown a benefit only for patients of long-term care facilities, critics reject extrapolation of these data into acute care settings based on the lack of proven benefit in hospitalized patients. Although there are no randomized studies proving that HCW influenza vaccination reduces mortality in hospitalized patients, more data have emerged which demonstrate the burden and importance of healthcare-associated influenza. The burden of healthcare-associated influenza and its relationship to ILI was evaluated in a prospective study of ILI in a French acute care hospital over three influenza seasons [51 ] . In this study, laboratory-confirmed influenza comprised 21.5% of all ILI in French HCWs through 3 years of ILI surveillance, nearly identical to 22.3% of laboratory-confirmed influenza seen in hospitalized patients as a whole and 20.3% of laboratory-confirmed influenza seen in hospitalized patients who did not have ILI on admission [51 ] . A striking result to this study was the significant increase in healthcare-associated ILI incidence based on exposure to HCWs or patients with ILI, peaking at an incidence rate ratio of 34.75 in patients exposed to both one patient and one HCW with ILI [51 ] . The authors suggested that some transmission to patients did occur among unvaccinated HCWs, but the efficacy of HCW influenza vaccination in preventing laboratory-confirmed influenza could not be evaluated [51 ] . This study provides solid evidence for healthcare-associated transmission of ILI, and by extension, influenza, and emphasizes the substantial patient risk associated with ILI exposures. The consistency of laboratory-confirmed influenza in healthcare-associated ILI cases also illustrates that healthcare-associated influenza is a substantial risk to patients [51 ] .
In response to concerns over mandatory HCW influenza vaccination, some have sought compromise by recommending a combined approach -mandatory vaccination of HCWs only in areas of vulnerable patient populations (ICUs, etc.) while using an opt-out approach for the rest [52 ] . Similarly, a recent study by Polgreen et al.
[53 ] used social network analysis to evaluate priority targets for HCW influenza vaccination. In this study, prioritization of HCW vaccination based on the number of expected close contacts outperformed a random vaccination strategy in simulations of influenza attack rates in the healthcare setting [53 ] . This strategy would likely be useful in the event of a vaccine shortage but does not appear feasible as a routine vaccination strategy. It is worth noting that all attempted simulations had minimal influenza transmission at high HCW vaccination rates [53 ] . Both a combined approach and a prioritization approach present institutional resource utilization and standardization of practice concerns. First, valuable resources are used in determining which HCWs require vaccination or reassignment based on refusal of vaccination. Second, requiring vaccination for only some HCWs could be misinterpreted as inequity by those HCWs for whom vaccination is required. Lastly, a disjointed vaccination strategy could increase the difficulty of tracking and reporting HCW influenza vaccination.
When considering influenza vaccine study methodology and vaccine efficacy, it is important to acknowledge that scientific criticism is useful and will improve future studies of influenza vaccination. However, infection control policy is informed by more than scientific evidence alone; patient and HCW safety, implementation strategy, practicality, cost, and administrative support are all factors in policy formation. We recommend mandatory HCW influenza vaccination because available evidence suggests that HCW vaccination does prevent influenza-related morbidity and mortality in vulnerable patients, at very low risk of harm to the HCW.
Influenza vaccination as a reported quality measure
Another strategy to improve HCW influenza vaccination coverage focuses on use of vaccination rates as a reported measure of quality and patient safety. Facility-specific HCW influenza vaccination rates are already a publically reported metric in some states [54] . In Iowa, a voluntary reporting system with statewide surveillance was associated with a median vaccination rate of 82% [55] . Recently, the National Quality Forum (NQF) endorsed a proposed measure for HCW influenza vaccination rates for use as a reportable process measure for healthcare-associated infection. This metric is currently being tested in a multistate study. One challenge with public reporting of vaccination rates revolves around how a program measures such coverage, including which HCWs are specifically included in the program. A recent survey of US hospitals showed large variability in the reporting of HCW influenza vaccination rates [56] . Many institutions do not target HCWs who are independently contracted or present as volunteers [56] , yet these employees are at no less risk of influenza transmission than other employees. Therefore, clarifying the reporting methodology and validating a standardized metric is essential prior to public reporting of this information.
Conclusion
HCW influenza vaccination rates remain far below recommended targets but new strategies to improve these rates have emerged. The current effectiveness of HCW influenza vaccination merits its use in healthcare settings to protect vulnerable hospitalized patients. Mandatory HCW influenza vaccination in the setting of a comprehensive infection control program is the most effective means to achieve a high HCW vaccination rate. Public reporting of institutional HCW influenza vaccination rates is another strategy, which will highlight the disappointing performance of most healthcare systems and magnify the need for improved HCW vaccination rates. Mandatory HCW influenza vaccination and public reporting of HCW vaccination rates will complement one another in achieving substantial gains for HCW influenza vaccination programs. 
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